Submit Deal

BOOSTER THERAPEUTICS

HQ - Berlin

Summary

Booster Therapeutics is a biotechnology company developing a new class of proteasome activator medicines to treat neurodegenerative and other diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 11 M

Avg. Deal Size£ 11 M

Market Context

Senior Management

Diogo Feleciano
Chief Scientific Officer

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy